Stocks On Sale Today: AAPL, BMY, And This One

view original post

(MENAFN– Baystreet) Walmart Lays off Some Managers, Relocates Others

  • Undiscovered Stocks: Lumentum, Fabrinet, and Good Year
  • Chevron Was The Most Shorted U.S. Stock In April
  • Watch These Stocks: Home Depot, Alibaba, Sony, and More
  • Home Depot Posts Mixed Results As Consumers Pullback Spending Previous Articles Subscribe to Get Small Cap News & Alerts Chris Lau – Tuesday, May 14, 2024 Stocks on Sale Today: AAPL, BMY, and This One

    The Magnificent 7 stocks are performing admirably but Apple (AAPL) has room to rise. Its price-to-earnings is below 30 times (at 28.97x). The iPad refresh is a starting step for getting consumers interested in its hardware again. As it rolls out the Vision Pro hardware outside of the U.S., fans will appreciate the company’s strategy in the VR headset market.

    Bristol-Myers (BMY) earned the title of being the only S&P 500 (SPY) stock dragging the index’s earnings growth lower.

    BMY stock traded at 52-week lows after posting a loss related to its acquisition of Karuna Therapeutics. It spent a massive $14 billion, betting that the firm’s schizophrenia drug will become a blockbuster product.

    In the first quarter, Bristol-Myers lost $4.40 a share.

    Gilead Sciences (GILD) is the other stock to watch. It bounced off a $65 low on no news. The firm reported a $1.32 non-GAAP EPS loss on revenue of $6.69 billion (+5.4% Y/Y). Trade GILD stock, knowing that the weak guidance limits the upside. The Immunomedics acquisition in 2020 cost Gilead around $21 billion. For the full year of 2024, the firm expects a non-GAAP EPS of $3.45 to $3.85. It previously expected $6.85 – $7.25.

    • About Us
    • Contact Us
    • Advertise
    • License Our Content
    • Jobs
    • Disclaimer
    • Privacy Policy

    Copyright 1998 – 2024 Baystreet Media Corp. All rights reserved. Nasdaq Stocks: Information delayed 15 minutes. Non-Nasdaq Stocks: Information delayed 20 minutes. Bid and Ask quotation information for NYSE and AMEX securities is only available on a real time basis. Market Data is provided by QuoteMedia. Earnings by Zacks. Analyst Ratings by Zacks

    MENAFN14052024000212011056ID1108211431

  • Legal Disclaimer:
    MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.